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1. Introduction 
Obesity and lack of physical activity are two major factors contributing considerably to the 
pathogenesis of many chronic diseases so prevalent in contemporary human population. 
Adipose tissue and skeletal muscle are therefore the primary organs one would immediately 
suggest to target in an attempt to battle metabolic disease progression. Fine tuning of the 
physiological processes within the two organs have a large potential to modulate (i) energy 
balance, (ii) lipid storage-utilization efficiency as well as (iii) central and peripheral actions 
in the brain, gastrointestinal system or liver which are integrated by the endocrine activity 
of the two energy balance maintaining tissues.  
2. Adipose tissue in metabolic health and disease  
Despite the fact that the primary role of adipose tissue is an effective lipid storage and 
timely regulation of its release and that these processes could, in a simplified adipocentric 
view, be the primary determinants of the dyslipidemia and metabolic disease progression, 
adipose tissue has a broad range of other regulatory functions exerted via its autocrine, 
paracrine and endocrine actions. Adipose tissue secretory products, “adipokines”, could 
modulate food intake, energy expenditure, or tissue oxidative capacity (Trayhurn et al. 1998; 
Ukropec et al. 2001; Ahima & Lazar 2008; Henry & Clarke 2008; Friedman 2011). In addition, 
adipose tissue dynamically changes its structure (tissue remodeling, lipid composition), 
function (lipid storage & lipolysis) as well as endocrine action in response to different 
physiological (fasting / refeeding, exercise, microgravity) and pathophysiological (obesity, 
prediabetes, diabetes, cachexia, lipodystrophy, growth hormone deficiency) conditions (Ukropec et 
al. 2008; Itoh et al. 2011; Pietilainen et al. 2011). It is important to understand that adipose 
tissue is a mixture of very different cell-types. Apart from approximately 50% of mature 
lipid-laden adipocytes it contains various stromal cells including preadipocytes, endothelial 
cells, fibroblasts, pluripotent stem cells and immune cells which substantially influence its 
function (Bjorntorp 1974; Sethi & Vidal-Puig 2007; Divoux & Clement 2011). Extreme 
enlargement of the fat cell size, such as we have recently observed in individuals with 
growth hormone deficiency, is perhaps the best early marker of the obesity related - 
metabolic disease development (Ukropec et al. 2008a) (Fig. 1.). Adipose tissue with enlarged 
adipocytes, expressing markers of the local tissue microhypoxia but not responding to it 
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properly and attracting large amount of activated immunocompetent cells, has recently been 
termed “pathogenic adipose tissue” (Bays et al. 2008; Ukropec et al. 2008b). 
 
 
Fig. 1. Fat cell size in obesity and in growth hormone deficiency (GHD), percentage of 
cumulative frequency (Y axis), (Ukropec et al. 2008a).  
The tissue damage due to overwhelming adipocytes with lipids, largely exceeding their lipid 
storage capacity, changes the adipokine secretory profile and leads to uncontrolled release of a 
large amount of lipids into circulation while the capacity of the adipose tissue adaptive 
remodeling is compromised. This is followed by the accumulation of lipids in tissues not 
designed for the lipid storage such as liver, skeletal muscle, pancreatic beta cells or lung which 
largely interferes with their physiological functions and accelerates the development of 
metabolic disease (Bays et al. 2008; Foster et al. 2010; Unger et al. 2010). Limited expandability 
of the adipose tissue seems to determine individual propensity to the development of 
metabolic disease (Arner, P. et al. 2011). Adaptive expansion of the adipose tissue is enabled by 
combination of adipocyte hypertrophy and hyperplasia. Expansion of adipose tissue requires 
quite extensive tissue remodeling, in order to maintain adequate energy and oxygen supply, 
active neuronal network as well as integrity and functional properties of cellular membranes 
(Itoh et al. 2011; Pietilainen et al. 2011). Broader knowledge of the fat cell life-cycle dynamics is 
critical for our understanding the pathophysiological mechanisms limiting adipose tissue 
hyperplastic expansion. In 2008, Arner’s group analyzed the adipocyte turnover by detecting 
the genomic DNA incorporation of atmospheric 14C derived from above-ground nuclear bomb 
tests in period between 1955 and 1963. This work revealed that approximately 10% of fat cells 
are renewed per year at all adult ages and levels of BMI and that neither adipocyte death nor 
generation rate is altered in early onset obesity. It seemed that the steady production of 
adipocytes in adults results in a stable size of the constantly turning over adipocyte population 
(Spalding et al. 2008). More recent work by these authors examining morphology of the 
subcutaneous adipose tissue from 764 individuals with broad range of BMI (18-60 kg.m2) 
defines hyperplasia and hypertrophy as a difference between measured adipocyte volume and 
volume predicted by the curve-like fit, for adipocyte volume and body fat mass (Fig. 2.). In this 
analysis occurrence of hyperplasia or hypertrophy correlated with fasting plasma insulin and 
insulin sensitivity. In addition, total adipocyte number was greatest in individuals with 
pronounced hyperplasia, and smallest in those with pronounced hypertrophy. The absolute 
number of new adipocytes generated each year was 70% lower in patients with hypertrophy 
than with hyperplasia. Whereas the relative death rate (~ 10% per year) or mean age of 
adipocytes (~ 10 years) was not correlated with adipocyte morphology (Arner, E. et al. 2010).   
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Fig. 2. (A) Graph depicts large variability in adipose tissue morphology in individuals with 
identical body fat mass (764 subjects). (B) Level of hyperplasia is represented by adequately 
lowered morphology value while hypertrophy is associated with parallel increase in 
morphology value defined as a difference between measured and expected adipocyte 
volume given by the curve-like fit , for given body fat mass (Arner, E. et al. 2010).    
Insulin sensitivity could therefore govern adipose tissue morphology towards beneficial 
hyperplastic state at the population level. Conversely, defects in insulin action are 
interconnected with the hypertrophic adipocytes, and higher risk of lipid flooding the 
nonadipose tissues. Absolute numbers of adipocytes as well as their capacity to expand and 
store lipids are quite difficult to modulate. Morbid obesity and lipodystrophy represent the 
two medical conditions associated with excessive hypertriglyceridemia, hepatic steatosis, 
and disordered muscle glucose metabolism, due to defected ability of adipose tissue to store 
lipids or the selective loss of adipose tissue respectively. Activation of adipogenic 
programme by PPAR agonists or chronic leptin treatment improves insulin-stimulated 
hepatic and peripheral glucose metabolism in obese and lipodystrophic patients 
respectively (Petersen et al. 2002; Rieusset et al. 2002; Van Gaal et al. 2003). Adipogenesis is 
necessary to increase the adipose tissue cellularity (hyperplastic adaptive change) and lipid 
storage capacity; it is largely dependent on the signal transducers and activators of 
transcription (STAT) pathway. In brief, transcription factors C/EBP, C/EBP, and PPAR 
control adipogenesis by regulating STAT5B and STAT5A. Regulation of PPAR-STAT5 by 
C/EBP signaling seems to be the crucial adipogenesis - initiating cascade of the various 
adipogenic genes (Jung et al. 2011). Activation of adipogenic program should be paralleled 
with the extracellular matrix remodeling. As mentioned above, adipocytes are embedded in 
a unique extracellular matrix which main function is to provide mechanical support, in 
addition to participating in a variety of signaling events. Extracellular matrix requires 
remodeling to accommodate growing adipocytes in the expanding adipose tissue. We have 
recently participated in the research by Christian Wolfrum’s laboratory investigating 
regulatory processes related to adipose tissue hyperplasia. In this work, the transcription 
factor retinoid-related orphan receptor Ǆ (RORǄ) was identified as an important regulator of 
adipocyte development through regulation of its newly identified target gene matrix 
metallopeptidase-3. RORǄ might serve as a novel predictor for the risk of metabolic 
complications in obesity as well as a pharmaceutical target for the treatment of obesity-
associated diseases (Meissburger et al. 2011).  
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Khan et al., recently proposed that "adipose tissue fibrosis" is a hallmark of metabolically 
challenged adipocytes. Authors observed that the absence of collagen VI, the highly enriched 
extracellular matrix component of adipose tissue, results in the uninhibited expansion of 
individual adipocytes, which is paradoxically associated with substantial improvements in 
whole-body energy homeostasis, both with high-fat diet exposure and in the ob/ob 
background. Weakening the extracellular scaffold of adipocytes seems to enable their stress-
free expansion during states of positive energy balance, which is consequently associated with 
an improved inflammatory profile (Khan et al. 2009). Further support to the notion that 
metabolic deregulation is rather due to lipid-leakage than the adipocyte hypertrophy per se 
comes from the experiment where mice lacking leptin were made to overexpress adiponectin. 
This led to the modest increase in circulating levels of full-length adiponectin and to 
subsequent normalization of glucose and insulin levels, dramatic improvement of glucose 
tolerance and positive effect on serum triglyceride levels. Adiponectin in fact completely 
rescued the diabetic phenotype in ob/ob mice. These mice displayed increased expression of 
PPAR target genes and a reduction in macrophage infiltration in adipose tissue and systemic 
inflammation. Adiponectin expressing ob/ob mice, however, were morbidly obese, with 
significantly higher levels of adiposity and adipocyte hypertrophy than their ob/ob 
littermates. Adiponectin seems to act as a peripheral "starvation" signal promoting the storage 
of triglycerides preferentially in adipose tissue. As a consequence, reduced triglyceride levels 
in the liver and muscle convey improved systemic insulin sensitivity despite adipocyte 
hypertrophy (Kim et al. 2007).  
2.1 Specificities of subcutaneous and visceral adipose tissue  
In contrast to visceral adipose tissue, which is often blamed from inducing detrimental 
metabolic effects, subcutaneous adipose tissue has the potential to benefit lipid and glucose 
metabolism. It has been repeatedly shown that differences in regional body fat distribution 
determine the propensity for the development of obesity related metabolic complications 
(Tchernof 2007). Accumulation of fat in the visceral region (mesentery, omentum, 
retroperitoneum), that in fact corresponds to central obesity (determined by increased waist 
circumference) is associated with cardiovascular disease and type 2 diabetes, independently 
on overall obesity (Wajchenberg 2000; Hamdy et al. 2006; Pischon et al. 2008). The amount of 
visceral fat increases with age in both genders but man in general have greater visceral 
adiposity than women (Wajchenberg 2000). Consistent with this notion, removal of visceral 
adipose tissue (omentectomy) decreases glucose and insulin levels in humans (Thorne et al. 
2002). By contrast peripheral obesity – increased subcutaneous adipose tissue mass, mainly 
in the region of buttock and thighs seem to be associated with improved insulin sensitivity 
and lower risk for type 2 diabetes mellitus (Snijder et al. 2003; Koska et al. 2008). One 
possible explanation for the detrimental effect of visceral fat accumulation comes from its 
unfortunate anatomical location (Arner, P. 1998; Bergman et al. 2006), but second theory 
based on adipose tissue transplantation experiments blames rather the tissue internal 
properties such as unfavorable secretory profile (Matsuzawa et al. 1999).   
Adipose tissue transplantation experiments have been primarily used as a tool to study 
physiology for human reconstructive surgery, but they provide important information on 
differences between visceral and subcutaneous adipose tissue which opens the vision of the 
adipose tissue or adipose tissue derived stem cells transplantation for the treatment of 
obesity and metabolic disorders.   
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2.2 Brown adipose tissue in human physiology  
Humans and other mammals have two types of adipose tissue that contribute to control of 
the whole body energy metabolism. The above discussed white adipose tissue, “the bad 
guy” associated with obesity, is necessary for energy storage. Brown adipose, “the good 
guy”, contains a lots of mitochondria and is ready to burn energy to generate heat in 
response to cold or dietary intake, keeping the body warm and slim (Cannon & Nedergaard 
2004). Until recently, physiologically relevant amount of brown fat was only found in 
newborns. However, accumulating evidence indicates that adult humans – or at least 
significant portion of us retain physiologically relevant amount of brown fat (van Marken 
Lichtenbelt et al. 2009; Vijgen et al. 2011; Virtanen & Nuutila 2011). This provides an exciting 
possibility to precisely regulate the adaptive thermogenic process in humans, which could 
dissipate energy and lower the obesity related metabolic burden. Brown adipose tissue 
activity in humans was determined with the aid of 18F-fluorodeoxyglucose positron-
emission tomography and computing tomography mainly in the supraclavicular region of 
cold-exposed individuals. Importantly, specimens of the adipose tissue from the 
supraclavicular region of adult humans with active brown adipose tissue were positive for 
UCP1 protein (Fig. 3.) (van Marken Lichtenbelt et al. 2009; Zingaretti et al. 2009). Vision of 
translating this knowledge into the clinical practice is quite reachable (Nedergaard & 
Cannon 2010; Tseng et al. 2010). Clinical importance could be significant, despite the fact 
that the volume of active brown adipose tissue tends to be lower in the overweight or obese 
than in the lean individuals (van Marken Lichtenbelt et al. 2009), and that it decreases with 
age (Cypess et al. 2009). Interestingly, applying the personalized cooling protocol for 
maximal nonshivering conditions to morbidly obese individuals could still increase brown 
adipose tissue activity (Vijgen et al. 2011).  
 
 
Fig. 3. Metabolically activated brown adipose tissue in supraclavicular region (arrows, B) in 
morbidly obese individuals after personalized cooling protocol (Vijgen et al. 2011). 
2.3 Metabolic activation of the white adipose tissue 
It has recently been shown that brown adipocytes and muscle cells share the common origin 
and in this respect they are quite distinct from white adipocytes (Tseng et al. 2008; Seale & 
Lazar 2009). The question remains, what is the origin of “brown fat-like white (brite) ” 
adipocytes containing UCP1 which could be induced in white fat depots under certain 
pohysiological (cold exposure) (Fig. 4.) or pharmacological (activation of SNS, agonists of 
PPAR) conditions (Granneman et al. 2005; Li et al. 2005; Ukropec et al. 2006). Nedegaard`s 
laboratory had recently reported that chronic treatment with the PPAR agonist 
rosiglitazone promotes not only the expression of PGC1 and mitochondriogenesis but also 
a catecholamine – inducible UCP1 gene expression in a significant subset of the white 
adipocytes, giving them the genuine, thermogenic capacity.  
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Fig. 4. Metabolically activated “brite adipocytes” as found in inguinal white adipose tissue 
of mice lacking the UCP1-thermogenesis after gradual exposure to cold.  
(A) histomorphology, (B) O2 consumption by oxymetry, (C) adipose tissue ex vivo  
palmitate oxidation, (D&E) evidence for AMPK activation (Ukropec et al. 2006). 
In collaboration with laboratory of dr. Kvatnansky we have recently observed that 
catecholamines, important regulators of lipolysis in adipose tissue, could be produced 
within adipocytes. Adipocytes isolated from mesenteric adipose tissue expressed genes 
encoding the catecholamine biosynthetic enzymes and produced catecholamines de novo. 
Administration of tyrosine hydroxylase inhibitor, alpha-methyl-p-tyrosine, significantly 
reduced concentration of catecholamines in isolated adipocytes in vitro (Fig. 5.). We 
therefore hypothesized that the sympathetic innervation of adipose tissue is not the only 
source of catecholamines and that adipocyte-derived catecholamines could dynamically 
modulate metabolic or thermogenic properties of the white adipose tissue perhaps by 
enhancing ”brite adipocyte” function (Vargovic et al. 2011). 
3. Adipocentric view on the pathophysiology of metabolic disease  
The prevalence of obesity and its consequent pathologies in modern society is of serious 
health concern. Although the expansion of adipose tissue mass during pathological obesity 
is in itself not a grave problem, rather it is the ensuing pathologies resultant of this state, 
including development of hypertension, type 2 diabetes and cardiac myopathies, that 
impacts peoples lives and health services worldwide.  
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Clearly not all obese individuals develop metabolic and cardiovascular complications; here 
we discuss several regulatory mechanisms representing a base for the strategies to prevent 
metabolic disease development.  
 
            d 
Fig. 5. Adipocytes have internal catecholamine production capacity. Adipose tissue contains 
mRNA and proteins specific for tyrosine hydroxylase (TH) and phenylethanolamine N-
methyltransferase PNMT as shown on histological sections probed with specific PNMT (a,b) 
and TH (c) antibodies, scale bar: 20 µm. (d) Adipocytes freshly isolated from mesenteric 
adipose tissue produce dopamine (DA), norepinephrine (NE) and epinephrine (EPI) into the 
media. Production of catecholamines is largely inhibited by addition of alpha-methyl-p-
tyrosine (AMPT) – competitive inhibitor of TH activity (Vargovic et al. 2011).  
3.1 Hypoxia  
Hypothesis that adipose tissue populated by large adipocytes contains the local 
microhypoxia suffering areas, which has a profound effect on the tissue metabolic and 
inflammatory phenotype, has been largely accepted. Hypoxia is one of the major triggers 
strongly inhibiting adipocyte differentiation. Tissue hypoxia in obesity is associated with the 
defects in the nutrient and oxygen supply into the tissue, related to a defective blood flow 
regulation which might be perpetuated by the increased fat cell size (Yun et al. 2002). This is 
happening in spite of the almost unlimited capacity of adipose tissue to expand in a non-
transformed form, which is a very unique property of adipose tissue that cannot be seen in 
any other organ. To accomplish this adipose tissue requires potent mechanisms to remodel, 
acutely and chronically, as it can rapidly reach the diffusional limit of oxygen; molecular 
response to hypoxia is therefore an early determinant that limits healthy adipose tissue 
expansion. Proper expansion requires a highly coordinated response among many different 
cell types, including endothelial precursor cells, immune cells, and preadipocytes (Sun et al. 
2011). It has also been demonstrated that mitochondrial oxidative apparatus is essential for 
the white fat adipocyte differentiation (De Pauw et al. 2009). Beside their key role in ATP 
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production, mitochondria constitute the primary source of reactive oxygen species (ROS), 
which have a great potential to influence the tissue plasticity.  
ROS are not only considered a negative factors contributing to degenerative processes and 
ageing, but also a physiological signal molecules participating in the oxygen sensing 
mechanisms (Chandel & Budinger 2007). Mitochondrial ROS production influences the size 
of the white adipocytes, and ROS are in fact antiadipogenic signaling molecules triggering 
the hypoxia-dependent inhibition of adipocyte differentiation (Carriere et al. 2004). In 
addition, decreased oxygen availability stimulates the programming of cellular metabolism 
towards increased glycolysis and fatty acid and triacylglyceride synthesis (Halperin et al. 
1969; Kinnula et al. 1978). Hypoxia-inducible factor (HIF), dimers composed of HIF1, 
HIF2 or HIF3 (collectively HIF) and HIF1/ARNT subunits, play a key role in the 
coordination of these metabolic adaptations (Trayhurn et al. 2008; Krishnan et al. 2009). 
HIF subunits are constitutively expressed but degraded under normoxia due to prolyl 
hydroxylase activity, which marks them for recognition by the von Hippel-Lindau (VHL) 
tumor suppressor protein pVHL, that acts as part of an E3 ubiquitin ligase complex to target 
HIF subunit for proteasomal degradation. Loss of pVHL function or hypoxia leads to 
accumulation of HIF, dimerization with HIF/ARNT and the activation of numerous 
hypoxia-inducible genes (Krek 2000; Semenza 2001). Previous work by Krek`s laboratory 
provided the seminal observation that hypoxia activated pVHL and HIF1 oxygen sensing 
system affects normal physiological function of heart and pancreatic beta cells by triggering 
the changes in the glucose and fatty acid metabolism (Zehetner et al. 2008; Krishnan et al. 
2009). Interestingly, hypoxia present in atherosclerotic lesions contributes to the pro-
inflammatory lipid-loaded foam cells formation, as it decreases expression of enzymes 
involved in -oxidation and increases expression of enzymes related to fatty acid synthesis 
and lipid droplet formation. The aforementioned processes possibly stimulate progression 
of the atherosclerotic plaque formation (Bostrom et al. 2007). Finally, tissue hypoxia largely 
modulates adipocytokine production and possibly contributes to the adipose tissue 
inflammation in obesity (Hosogai et al. 2007; Wang et al. 2007; Ukropec et al. 2008). 
3.2 Inflammation – Macrophage, adipocyte and preadipocyte plasticity  
Chronic low level of inflammation present in the “pathogenic” adipose tissue has been 
found to have adverse effects on the adipose tissue physiological functions contributing thus 
to the metabolic disease. It has been shown that increase in both body fat mass and 
adipocyte cell size are directly related to the number of macrophages found in the adipose 
tissue (Wellen & Hotamisligil 2005; Weisberg et al. 2006; Goossens 2008). A net pro-
inflammatory response of the adipose tissue may result from adipose tissue secretion of pro-
inflammatory factors; adipose tissue secretion of factors that stimulate other tissues to 
produce inflammatory factors; and decreased production of anti-inflammatory factors. 
Although the contribution of specific cell types to inflammation is uncertain, evidence is 
mounting that implicates adipose tissue macrophages as the significant contributor to 
inflammation in insulin resistant adipose tissue (Kanda et al. 2006; Neels & Olefsky 2006). 
There are controversial reports related to the importance of the CC chemokine ligand 2 
(CCL2, monocyte chemoattractant protein-1) for the macrophage-recruitment and activation 
in obesity (Kamei et al. 2006; Inouye et al. 2007). Interestingly CCL2 has also been proposed 
to affect metabolism independently of its macrophage-recruiting capabilities (Inouye et al. 
2007). There is also preliminary data indicating that the tissue infiltration by macrophages 
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depends upon the expression of osteopontin, an extracellular matrix protein and pro-
inflammatory cytokine which promotes the monocyte chemotaxis and cell motility. Mice 
exposed to a high-fat diet exhibited increased plasma osteopontin level, and elevated 
expression of osteopontin in macrophages recruited into adipose tissue. In addition, obese 
mice lacking osteopontin displayed improved insulin sensitivity in the absence of an effect 
on the diet-induced obesity, body composition or energy expenditure. These mice further 
demonstrated decreased macrophage infiltration into adipose tissue, which may reflect both 
impaired macrophage motility and attenuated monocyte recruitment by stromal vascular 
cells. Finally, obese osteopontin-deficient mice exhibited decreased markers of 
inflammation, both in adipose tissue and systemically (Nomiyama et al. 2007).  
Adipose tissue resident macrophages show significant heterogeneity in their properties and 
activation state, reflecting the local metabolic and immune microenvironment (Gordon & 
Taylor 2005). Different stimuli activate macrophages to express distinct patterns of 
chemokines, surface markers and enzymes that ultimately generate the diversity of 
macrophage function seen in inflammatory and non-inflammatory settings. It has recently 
been proposed that adipose tissue macrophages, which accumulate with obesity and are 
implicated in insulin resistance switch their phenotype from one of an alternatively 
activated (M2) to pro-inflammatory (M1) cells (Lumeng et al. 2007). Characteristic features 
of the IFN- induced pro-inflammatory (M1) macrophages include enhanced MHC class II 
expression, but distinctive up-regulation of i-NOS. Alternative activation of macrophages 
(M2) is strongly associated with extracellular parasitic infections, allergy, humoral 
immunity, and fibrosis. It is characterized by up-regulation of the endocytic lecithin-like 
receptors and arginase rather than i-NOS (Gordon 2007). Therefore, the alternatively 
activated (M2) macrophages seem to have high capacity for the tissue remodeling and 
repair.  
It had been recently proposed that PPARǄ is required for maturation of alternatively 
activated macrophages (M2), which could also participate to its insulin sensitizing effect 
(Odegaard et al. 2007). Disruption of PPAR in myeloid cells impaired alternative 
macrophage activation and predisposed to the development of diet-induced obesity, insulin 
resistance, and glucose intolerance. This might be related to the concomitant down-
regulation of oxidative phosphorylation gene expression in skeletal muscle and liver 
(Odegaard et al. 2007). Phenotype of macrophages in the pathogenic-hypoxic adipose tissue 
might also be regulated by HIF-1 since the functional loss of HIF-1α resulted in a dramatic 
reduction of the intracellular ATP stores in macrophages to approximately 15-20%, most 
likely due to the inhibition of the HIF-1α regulated glycolytic energy generation (Cramer & 
Johnson 2003; Cramer et al. 2003). It could be hypothesized that resident alternatively 
activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest 
that macrophage polarization towards the alternative state might be a useful strategy for 
treating type 2 diabetes, by modulating adipose tissue phenotype.  
Fatty acid binding proteins (FABPs), which are common to adipocytes and macrophages, 
could also play an important role in metabolic and inflammatory disease, and might 
therefore represent desirable therapeutic targets for metabolic syndrome (Erbay et al. 2007). 
Macrophage-derived foam cells express the adipocyte fatty acid-binding protein (FABP) aP2 
that plays an important role in regulating the development of insulin resistance in obesity. It 
has been shown that macrophages deficient in aP2 display alterations in the inflammatory 
cytokine production. Through its distinct actions in adipocytes and macrophages, aP2 links 
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together the features of the metabolic syndrome including insulin resistance, obesity, 
inflammation, and atherosclerosis (Linton & Fazio 2003). 
3.3 Phospholipid membrane composition  
In the last decades, free radical processes delineated an interdisciplinary field linking 
chemistry to biology and medicine. Free radical mechanisms became of importance as 
molecular basis of physiological and pathological conditions. Lipids, in particular 
unsaturated fatty acids, are susceptible to free radical attack. The reactivity of the double 
bond toward free radicals is well known; in particular the reversible addition of radical 
species to this functionality determines the cis-trans double bond isomerization. Since the 
prevalent geometry displayed by unsaturated fatty acids in eukaryotes is cis, the occurrence 
of the cis-trans isomerization by free radicals corresponds to the loss of an important 
structural information linked to biological activity (Ferreri & Chatgilialoglu 2009). 
Formation of trans isomers of unsaturated fatty acid in biological membranes can have 
important meaning and consequences connected to radical stress associated with nutritional 
overload and mitochondrial defects. It might, together with changes in membrane lipid 
composition (Pietilainen et al. 2011), substantially modulate lipid membrane biophysical 
characteristics such as thickness, fluidity, protein lateral diffusion capacity, permeability to 
small molecules in expanding adipocytes and contribute thus to the development of 
metabolic disease in obesity.  
3.4 Pollutants and metabolic health  
Physical inactivity and unhealthy diet are well recognized environmental influences largely 
increasing the risk for metabolic disease development. Recent advances in detecting the 
presence of various persistent organic pollutants in the surrounding world as well as within 
our bodies, prompted us to evaluate its possible role in pathogenesis of different endocrine 
and metabolic pathological states (Langer et al. 2003; Langer et al. 2007; Langer 2010; Langer 
et al. 2010; Ukropec et al. 2010; Langer et al. 2011).  
A heavily polluted area of Eastern Slovakia was targeted by the PCBrisk cross-sectional 
survey to search for possible links between environmental pollution and both prediabetes 
and diabetes. Associations of serum levels of five persistent organic pollutants (POPs), 
namely polychlorinated biphenyls (PCBs), 2,2'-bis(4-chlorophenyl)-1,1-dichloroethylene 
(p,p'-DDE), 2,2'-bis(4-chlorophenyl)-1,1,1-trichloro-ethane (p,p'-DDT), hexachlorobenzene 
(HCB) and beta-hexachlorocyclohexane (-HCH), with prediabetes and diabetes were 
investigated in 2,047 adults. Prevalence of prediabetes and diabetes increased in a dose-
dependent manner, with individuals in upper quintiles of individual POPs showing striking 
increases in prevalence of prediabetes (Fig. 6.) Interestingly, unlike PCBs, DDT and DDE, 
increased levels of HCB and -HCH seemed not to be associated with increased prevalence 
of diabetes (Ukropec et al. 2010). Cumulative effect of all five persistent organic pollutants 
(sum of orders) more than tripled the prevalence of prediabetes while that of diabetes was 
increased more than six times as compared to the referent quintile composed of individuals 
with lowest levels of pollutants in serum. We as well as the others have clearly shown that 
increasing serum concentrations of individual persistent organic pollutants considerably 
increased prevalence of prediabetes and diabetes in a dose-dependent manner. Interaction 
of industrial and agricultural pollutants in increasing prevalence of prediabetes or diabetes 
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is likely (Hong et al. 2010; Ukropec et al. 2010; Howard & Lee 2011; Lee, D. H. et al. 2011; 
Lee, D. H. et al. 2011; Lee, H. K. 2011). 
 
 
Fig. 6. The prevalence of prediabetes increases with increased circulating levels of PCBs 
(sum 15 congeners of polychlorinated biphenyls); DDE (2,2'-bis(4-chlorophenyl)-1,1-
dichloroethylene); DDT (2,2'-bis(4-chlorophenyl)-1,1,1-trichloro-ethane); HCB 
(hexachlorobenzene) and b-HCH (beta-hexachlorocyclohexane); POLL5 represents the sum 
of orders for all 5 pollutants. Odds ratios were adjusted for age, gender and BMI.  
4. Skeletal muscle in metabolic health and disease  
Skeletal muscle represents a large mass of tissue, and its primary function is to use 
energy, though quite inefficiently, to enable us the 3D life, voluntary positioning and 
moving our bodies in a surrounding space. This makes an active muscle to be the most 
effective energy burner. In addition to obvious metabolic consequences, regular exercise 
activates central reward mechanisms and makes us happy (Figure 7.) (Sher 1998; Boecker 
et al. 2008). 
 
A      B 
 
Fig. 7. Correlation of opidergic ligand 6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine 
binding in right orbitofrontal cortex (OFC) with the visual analog mood scale (for euphoria) 
in runners (A) and effect of exercise on the individual’s mood expressed in the visual analog 
mood scale (B) (Boecker et al. 2008).  
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More importantly, inadequate physical activity, associated with defects in mitochondrial 
function and changes in ultrastructure as well as muscle endocrine properties, largely 
contributes to the imbalance between energy intake and energy expenditure and is tightly 
associated with many chronic metabolic and cardiovascular diseases (Bluher & Zimmer 
2010; Pedersen 2011). Physical activity is a key factor to bring individuals living in a 
modern society with plenty of palatable food choices to energy balance. The mechanisms 
that tie muscle activity to health are unclear. Generation of “exercise pill” targeting organ 
systems involved in facultative thermogenesis had been envisaged (Himms-Hagen 2004). 
And results of studies aimed at identifying the endocrine properties of exercising muscle 
are encouraging our thinking in this respect. In our recent study we observed on the 
sample of 71 individuals with a broad range of BMI that overweight and obesity is 
associated with decreased physical activity. This might be not so surprising. But low 
physical activity level was also associated with decreased insulin sensitivity, increased fat 
cell size and expanded visceral adiposity all independent on BMI (Fig. 8.). In addition, the 
basic metabolic rate was positively and respiratory quotient negatively associated with 
the duration of the daily physical activity representing thus a direct link between physical 
activity and major determinants of energy homeostasis (Ukropcova et al., unpublished 
observations).  
 
 
Fig. 8. Free-living ambulatory activity (number of steps in 24h) correlates with insulin 
sensitivity, modulates adipocyte diameter as well as visceral adiposity (Ukropcova et al., 
unpublished observations).    
This complements the previous observations by others indicating that inactivity initiates 
unique cellular processes that are qualitatively different from the exercise responses. 
Inactivity physiology studies are beginning to raise a new concern with potentially major 
clinical and public health significance. Sedentary lifestyle threatens our society. The average 
nonexercising person may become even more metabolically unfit in the coming years if they 
sit too much and thereby lower the normally high volume of intermittent nonexercise 
physical activity in everyday life (Fig. 8) (Hamilton et al. 2007; Levine et al. 2008). Dynamic 
interrelations of skeletal muscle and adipose tissue during exercise are necessary to support 
muscle performance. This requires precise spacio-temporal management of the adipose 
tissue metabolic flux. The transcriptional coactivator PGC1 has recently been shown to 
regulate several exercise-associated aspects of muscle function. There is mounting evidence 
suggesting that this transcription factor controls muscle plasticity, suppresses a broad 
inflammatory response and integrates many beneficial effects of exercise on metabolic 
health (Handschin & Spiegelman 2008).  
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4.1 Exercise and skeletal muscle endocrinology  
The recent identification of skeletal muscle as an endocrine organ that produces and releases 
biologically active substances, ”myokines”, expands our knowledge on how the endocrine, 
immune and nervous systems contribute to the maintenance of homeostasis, especially 
when energy demands are increased (Pedersen & Febbraio 2008). To date, only a few muscle 
cell-secreted proteins with auto-, para-, or endocrine functions have been identified. It could 
be hypothesized that skeletal muscle releases a large number of biologically active 
substances which participate to cell-to-cell and organ-to-organ cross-talk. It also has to be 
noted that specific biological functions of known myokines are very incompletely 
understood.  
Certain myokines, such as calprotectin (Mortensen et al. 2008), IL15 (Nielsen & Pedersen 
2007) and IL6 (Jonsdottir et al. 2000), are acutely induced by muscle contraction but might 
not necessarily be increased in response to muscle training (Pedersen & Febbraio 2008; 
Haugen et al. 2010). Exercise training involves multiple adaptations including increased pre-
exercise skeletal muscle glycogen content (Kirwan et al. 1990), enhanced activity of key 
enzymes involved in -oxidation (Schantz 1986), increased sensitivity of adipose tissue to 
epinephrine-induced lipolysis (Crampes et al. 1986), and increased muscle capacity to 
oxidize fat (Holloszy & Booth 1976; Phillips et al. 1996). It could therefore be hypothesized 
that secretory activity of muscle subjected to inadequate physical activity would be 
qualitatively and quantitatively distinct from that of the trained athlete, and that it could 
simply be regulated by e.g. the glycogen level (Keller et al. 2001; Steensberg et al. 2001), 
reactive oxygen species production (Kosmidou et al. 2002; Steensberg et al. 2007) or by 
modulating biological availability of various forms of lipids (Peter et al. 2009), such as found 
in obesity.  
Previous reports indicate that calprotectin, IL6 and IL15 might contribute to homeostatic 
control of glucose and lipid metabolism (Van Hall et al. 2003; Febbraio et al. 2004). In 
addition, fibroblast growth factor-21 (FGF-21), the potent metabolic regulator, shown to 
improve glucose metabolism and insulin sensitivity in animal models, had recently been 
found to be expressed and secreted in vitro from murine muscle cells and in vivo from 
human muscle in response to insulin stimulation (hyperinsulinemic-euglycemic clamp) 
(Hojman et al. 2009). Follistatin-like 1 (Fstl-1) is another myokine whose functional 
significance in physiological and pathological processes is incompletely understood. 
Preliminary evidence indicates that Fstl-1 promotes endothelial cell function and stimulates 
revascularization in response to ischemic insult through its ability to activate Akt-eNOS 
signaling in muscle (Ouchi et al. 2008). Interleukin-8 is a CXC family chemokine increased in 
human muscle in response to concentric exercise (Akerstrom et al. 2005), which has also 
been shown to have angiogenic actions associated with activation of CXCR2 receptors in the 
human microvascular endothelial cells (Bek et al. 2002; Frydelund-Larsen et al. 2007). Recent 
report by Drevon’s laboratory describes interleukin-7 as a novel myokine affecting 
myogenesis in vitro in human primary muscle cells. Interleukin-7 is up-regulated by exercise 
training in male individuals undergoing a strength training program (Haugen et al. 2010). 
4.2 Mitochondrial biogenesis in skeletal muscle – Energetic remodeling of muscle 
phenotype in obesity, insulin resistance and exercise  
Mitochondria are energy power plants of the cells, believed to have evolved over billions of 
years from invading prokaryotic oxygen utilizing “quite energizing” eubacterium to early 
eucaryotic cells, giving the life on earth new energy spark (Lanza & Nair 2010). Their 
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structure and function is orchestrated by a strict coordination of nuclear and mitochondrial 
genome. Of ~1.000 mitochondrial proteins, only 13 are encoded by the mitochondrial 
genome, remaining proteins are translated from nuclear genome and transported across the 
inner mitochondrial membrane (Lanza & Nair 2010). Mitochondria cover majority of 
energetic needs of cells by coupling substrate oxidation with ATP formation, the process 
known as oxidative phosphorylation. This process also generates reactive oxygen species 
(ROS). It has been estimated that 0.2 – 2% of oxygen taken up by the cell is converted into 
ROS (Harper et al. 2004). Mechanisms for detoxifying the ROS are quite well developed in a 
eukaryotic cell which is another reason for their long lasting partnership with “dangerous” 
mitochondria. Sustained excessive production may accumulate amount of ROS exceeding 
the antioxidant capacity of the specific cell, eventually leading to cell damage and death 
(Harman 1956). During recent years, mitochondria , though not only those found in skeletal 
muscle, were put on the spot as organelles involved in aging and associated chronic 
civilization diseases such as Alzheimer’s disease (Reddy 2009), some forms of cancer, 
obesity and type 2 diabetes (Johannsen & Ravussin 2009).  
4.2.1 Mitochondria in obesity, insulin resistance and type 2 diabetes  
Recent evidence indicates that insulin resistance in skeletal muscle might develop due to the 
reduced capacity of mitochondria to oxidize lipids (Bjorntorp et al. 1967; Kelley et al. 2002; 
Petersen et al. 2004; Ukropcova et al. 2007) and reduced capacity for insulin-stimulated ATP-
synthesis (Petersen et al. 2005). Obese individuals and subjects with type 2 diabetes are 
characterized also by reduced adiponectin signaling (Kern et al. 2003; Civitarese et al. 2004; 
Rasmussen et al. 2006), lower rates of fasting lipid utilization and impaired switch to 
carbohydrate oxidation in response to insulin (Kelley et al. 1999; Kelley & Mandarino 2000; 
Ukropcova et al. 2005; Ukropcova et al. 2007). Recent studies using microarray expression 
analysis reported a decrease in the expression of genes involved in mitochondrial biogenesis 
in skeletal muscle of individuals with insulin resistance (Patti et al. 2003) and T2D (Mootha 
et al. 2003). Further studies in insulin resistant subjects and individuals with type 2 diabetes 
have shown reduced mitochondrial content, lower electron transport chain activity in total 
mitochondria and in intramyofibrilar and subsarcolemal mitochondrial fractions (Kelley et 
al. 2002; Ritov et al. 2005). Taken together, these data support the hypothesis that insulin 
resistance in human skeletal muscle arises from lowering mitochondrial number and 
functional capacity. Another hypothesis challenges this paradigm; it is supported by 
observations that increased fatty acid availability is associated with increased mitochondrial 
fat oxidation. However, mitochondrial overload with energy rich substrates highlights the 
pathophysiological role of ROS and that of products of incomplete mitochondrial oxidation 
rather than simple lowering of mitochondrial functional capacity (Koves et al. 2008; 
Holloszy 2009). The importance of mitochondria for energy homeostasis makes this 
organelle an exciting target for investigation and better understanding to regulation of 
mitochondrial biogenesis and function would help us to understand its putative role in the 
pathogenesis of obesity and insulin resistance.  
4.2.2 Exercise and ageing keep constant battle for healthy mitochondria 
Exercise is one of the two physiological stimuli known to increase production of new 
mitochondria and to improve mitochondrial efficiency. In our work, we have shown that 
caloric restriction, the only officially acknowledged physiological stimulus demonstrated to 
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prolong lifespan, is also inducing mitochondrial biogenesis in human skeletal muscle 
(Civitarese et al. 2007). Many scientists are on a quest, pursuing the vision of exercise 
mimicking pill, capable of induction of mitochondrial biogenesis in vivo. „Exercise in a pill“ 
(another option would be a pill mimicking caloric restriction) is by many considered a 
putatively great tool to combat obesity and civilization diseases. However, healthy lifestyle 
intervention, with sufficient physical activity and matching caloric intake still proves to be 
the most natural and effective way how to stay fit, healthy and with increased chances to 
live up to be a hundred.  
4.2.3 Adipose tissue and skeletal muscle interplay  
Our organism can be viewed as a very complex society of tissues that need to communicate 
with one another in order to maintain metabolic health. Tissue cross-talk plays the central 
role in the regulation of food intake, energy expenditure, oxidative capacity, adaptation to 
changes in physical activity, nutritional status etc. As mentioned above, adipose tissue (as 
well as many other tissues in our body) is (are) a (the) source of many biologically active 
substances with autocrine, paracrine and endocrine activities, exerting effects over many 
different neighboring as well as distant tissues and organs. 
Adiponectin is the most studied adipocytokine which is in relatively high quantities 
secreted from adipose tissue into the bloodstream. Adiponectin has very positive effects on 
our metabolic health as it activates glucose and fatty acid metabolism and improves insulin 
sensitivity. Adiponectin levels are inversely correlated with body fat mass and positively 
with insulin sensitivity (Hara et al. 2005) and it also displays anti-atherogenic and anti-
inflammatory effects (Antoniades et al. 2009). This hormone was first characterized in mice 
as a transcript overexpressed in preadipocytes (precursors of fat cells) differentiating into 
adipocytes. The human homologue was identified as the most abundant transcript in 
adipose tissue. Contrary to expectations and despite being produced in adipose tissue, 
adiponectin was found to be decreased in obesity. The gene was localized to chromosome 
3p27, a region highlighted as affecting genetic susceptibility to T2D and obesity. 
Supplementation by differing forms of adiponectin was able to improve insulin control, 
blood glucose and triglyceride levels in mouse models. The question remains what are the 
mechanisms underlying positive effects of adiponectin on metabolism? 
The molecular mechanisms leading to mitochondrial dysfunction in obesity and T2D remain 
largely unknown. Bergeron et al (Bergeron et al. 2001) demonstrated that activation of 
cAMP-activated protein kinase (AMPK) increases both mitochondrial biogenesis and 
oxidative capacity in skeletal muscle of rodents. In animal models of T2D, the activation of 
AMPK by adiponectin increases muscle and hepatic fat oxidation and improves insulin 
sensitivity (Yamauchi et al. 2001). Studies in obese and diabetic rhesus monkey demonstrate 
that plasma adiponectin level declines in the early phases of obesity and in parallel to the 
progressive development of insulin resistance (Hotta et al. 2001). Furthermore, circulating 
plasma adiponectin levels and the expression of both adiponectin receptors are reduced in 
subjects with a family history of diabetes (Civitarese et al. 2004), while prospective studies in 
Pima Indians show that high concentrations of adiponectin is protective against the 
development of T2D (Lindsay et al. 2002). Collectively, these data define a pathway in 
skeletal muscle by which adiponectin contributes to energy homeostasis by modulating 
mitochondrial number and function (Civitarese et al. 2006). Early defects in the secretion of 
adiponectin or in adiponectin signaling might contribute to the lower mitochondrial content 
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and/or function in the prediabetic state. Interestingly and in accordance with our results, it 
has been recently demonstrated that an adiponectin-like molecule, a recombinant globular 
domain of adiponectin (rgAd110-244), has a significant therapeutic potential to treat insulin 
resistance in mice fed a high fat diet for 3 months (Sulpice et al. 2009). This makes 
adiponectin derivatives a promising new treatment for T2D.  
It appears that adiponectin is also produced by skeletal muscle and that globular 
adiponectin is capable of inducing the differentiation and fusion of muscle cells in vitro 
(Fiaschi et al. 2009). Mimicking of pro-inflammatory settings or exposure to oxidative stress 
strongly increases the production of adiponectin from differentiating primary muscle cells. 
These data suggest a novel function of adiponectin, coordinating the myogenic 
differentiation program. 
4.2.4 Mitochondrial biogenesis in muscle cells – Lipids and exercise  
Fatty acids are known to be the ligands of various transcription factors involved in the 
regulation of metabolism and mitochondrial biogenesis (Gilde & Van Bilsen 2003). It has 
been shown previously that fatty acids as well as a diet with an increased fat content is 
capable of inducing mitochondrial biogenesis both in vitro and in vivo (Watt et al. 2006; 
Hancock et al. 2008). In our work, we have tested the effect of chronic, 4-day long exposure 
to palmitate on metabolic phenotypes of human primary skeletal muscle cells. We observed 
an increase in number of active mitochondria as measured by incorporation of mitotracker 
(fluorescencent dye selectively activated within respiring mitochondria) as well as increased 
expression of genes involved in mitochondrial biogenesis, increase in the capacity for fatty 
acid oxidation (Ukropcova et al. 2005, Ukropcova et al, unpublished observation). At this 
moment we can only speculate on the mechanisms behind this oxidation boosting effect of 
palmitate. However, it has been shown that fatty acids are capable of activating AMP 
activated protein kinase (AMPK) in skeletal muscle (Watt et al. 2006). AMPK signaling is 
activated in energy deficit states and it primarily saves the cell by inducing de novo 
mitochondrial biogenesis. It cooperates with transcription factor PGC1, overexpression of 
which has been demonstrated to enhance both lipid oxidation and synthesis (Espinoza et al. 
2010). Another possibility is that palmitate is a ligand for the transcription factors involved 
in the regulation of cell´s oxidative capacity, such as PPARǅ (Gilde & Van Bilsen 2003). 
Animal (Hancock et al. 2008) as well as clinical studies (Bajaj et al. 2007) also support the 
role of fatty acids for PGC1 regulation at the level of gene expression. We and others have 
indicated that saturated fatty acids (e.g. palmitate) contribute to the regulation of 
metabolism by self-promoting their utilization via increased oxidative capacity of the 
skeletal muscle cell.  
In addition, dynamic interrelations of skeletal muscle and adipose tissue during exercise are 
necessary to support muscle performance and adipose tissue energy fluxes management. 
The transcriptional coactivator PGC1 has also been shown to regulate several exercise-
associated aspects of muscle function. It could be hypothesized that this protein controls 
muscle plasticity, suppresses a broad inflammatory response and mediates the beneficial 
effects of exercise on metabolic health (Handschin and Spiegelman 2008).  
4.2.5 Caloric restriction induces mitochondrial biogenesis in skeletal muscle 
Caloric restriction is a non-genetic manipulation that results in the lifespan extension of 
many different species, from yeasts to dogs, and even primates, and it is accompanied by 
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delayed onset of chronic civilization diseases (Ball et al. 1947; Anderson et al. 2009). There 
are also hints that people who eat a calorie-restricted diet might live longer than those 
who overeat. People living in Okinawa, Japan, have a lower energy intake than the rest of 
the Japanese population and an extremely long life span (Willcox et al. 2007). In addition, 
calorie-restricted diets beneficially affect several biomarkers of aging, including decreased 
insulin sensitivity. Based on combined favorable changes in lipid and blood pressure, 
caloric restriction with or without exercise induces weight loss and favorably reduces risk 
for cardiovascular disease even in healthy non-obese individuals (Lefevre et al. 2009) and 
ameliorates the age-related loss of muscle mass, sarcopenia, in a variety a species 
(Marzetti et al. 2009). But how might caloric restriction slow aging? Some of the theories 
behind the lifespan extending effect of caloric restriction include (i) decreased oxidative 
damage, (ii) altered glucose utilization, (iii) increased insulin sensitivity, (iv) 
neuroendocrine changes and (v) enhanced stress responsiveness (Allard et al. 2009). 
Reduction of oxidative damage to proteins, lipids, and DNA is one of the leading theories, 
although the underlying mechanisms of this process are unclear. Cellular nutrient sensing 
systems seem to mediate many of the metabolic responses to caloric restriction, including 
the regulation of free radical production and oxidative stress. Mitochondria are the major 
consumers of cellular oxygen (~85%) and the predominant production site of free radicals, 
a by-product of oxidative phosphorylation. Studies in mammals have shown that caloric 
restriction reduces the generation of free radicals by mitochondria, in parallel to 
reductions in mitochondrial proton leak and whole-body energy expenditure. 
Paradoxically, caloric restriction induces mitochondrial proliferation in rodents (Lanza & 
Nair 2010), and either lowers (Handschin & Spiegelman 2008) or does not affect 
mitochondrial oxygen consumption (Lanza & Nair 2010). Low mitochondrial content 
seems to contribute to increased ROS production. When mitochondrial mass is reduced, 
mitochondria have increased “workload,” leading to higher membrane potential and 
increased ROS production (Handschin & Spiegelman 2008; Lanza & Nair 2009; Lanza & 
Nair 2010). It has also been demonstrated that caloric restriction is strongly associated 
with an increased level and activation of sirtuins, namely the Sir2 histone deacetylase and 
its mammalian ortholog Sirt1. Sirtuins are members of the silent information regulator 2 
(Sir2) family, a family of Class III histone/protein deacetylases. The enzymatic activity of 
most sirtuins has been shown to be dependent on nicotinamide dinucleotide, suggesting 
that the activity of these enzymes is dependent on the nutritive state of the organism 
(Allard et al. 2009). Specific Sirt1 activation mimics low energy levels and protects against 
diet-induced metabolic disorders by enhancing fat oxidation (Feige et al. 2008). PGC1α is 
a transcriptional coactivator playing a pivotal role in the regulation of mitochondrial 
biogenesis, which is known to be induced in response to exercise and caloric restriction 
(Fig. 8.). Research strongly supports the health benefits of exercise in humans of all ages. 
Increased exercise in the absence of other behavioral changes prevents the onset of many 
chronic diseases (Elbekai & El-Kadi 2005).  
In our study we showed that short-term caloric deficit (caloric restriction with or without 
exercise) coordinately up-regulated the expression of genes involved in mitochondrial 
biogenesis in skeletal muscle resulting in increased mitochondrial content, improved whole 
body energy efficiency, and decreased DNA fragmentation in non-obese humans (Civitarese 
et al. 2007). Our results suggest that caloric restriction induces biogenesis of “efficient” 
mitochondria as an adaptive mechanism, which in turn lowers oxidative stress.  
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Fig. 9. The free radical theory of aging posits that a senescent phenotype is induced by 
accumulation of oxidative damage resulting from reactive oxygen species. Exercise and 
caloric restriction (CR) are two interventions that induce mitochondrial biogenesis through 
PGC-1α. Although exercise and CR increase average life expectancy by protecting against 
age-related comorbidities, only CR has been shown to increase maximal life span; an effect 
that seems to require the activation of sirtuins (Lanza & Nair 2010).  
 
Fig. 10. Determinants of metabolic health and disease (Ukropec et al. 2008) 
5. Conclusion 
Ability of tissues to adapt morphologically and functionally to different physiological 
situations determines the overall metabolic health. Increased adipose tissue mass but mainly 
adipocyte lipid overload is responsible for the “pathogenic” adipose tissue phenotype. This 
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phenotype, characteristic by extra-large unilocular adipocytes, further promotes tissue 
hypoxia and development of chronic persistent inflammation and metabolic stress. 
Pathogenic modification of the adipocyte modulates its metabolic, secretory and 
immunologic function leading to the development of metabolic disease (Fig. 10.). Inactive 
skeletal muscle, overloaded with fat could also contribute to metabolic imbalance by 
switching the fiber type towards less oxidative (less insulin sensitive) fibers, by lack of anti-
inflammatory and insulin-sensitizing myokine production as well as by chronic 
inflammation associated with mitochondrial stress and stress of endoplasmic reticulum (Fig. 
10.). Our environment greatly modifies our metabolic health by means of dietary influences 
and exercise activity which together with pathologies associated with hyperlipidemia, 
chronic systemic hypoxia and tissue inflammation determines adipose tissue and skeletal 
muscle metabolic and secretory phenotype and subsequently our metabolic health.  
It is generally accepted that regular physical activity prevents metabolic and cardiovascular 
disease development, and supports healthy aging. Skeletal muscle has been shown to 
produce and secrete several bioactive factors (hormones) termed “myokines”. Different 
spectra of myokines originating from either active ”trained” or inactive “sedentary” skeletal 
muscles elicit distinct adaptive changes in immune system, metabolic balance and processes 
of cellular growth and differentiation in order to maintain the whole body homeostasis. This 
requires extensive communication of skeletal muscle with many different cells and organs 
but the nature of mechanisms that tie muscle activity to metabolic health is not completely 
understood. It seems to be essential (i) to identify myokines differentially expressed and 
secreted from muscle cells derived from healthy and obese individuals, and individuals 
with type 2 diabetes; to (ii) determine basic principles of the muscle cross-communication 
with adipocytes (differentiation) and endothelial cells (angiogenesis) in fostering tissue 
plasticity necessary for adaptation to obesity and type 2 diabetes; and (iii) to discover novel 
myokines and to investigate their physiological significance in cell culture models and in 
vivo in genetically modified animal models as well as in humans. Myokines may be involved 
in mediating the health beneficial effects of exercise and play important roles in the 
protection against chronic diseases associated with low-grade inflammation, insulin 
resistance, hyperlipidemia, such as cardiovascular disease, type-2-diabetes, and cancer. 
Extension of the knowledge on the mechanisms whereby regular exercise offers protection 
against chronic diseases in combination with clinical research serves as a foundation for the 
development of public health guidelines with regard to exercise. Moreover, identification of 
new myokines and understanding basic principles and mechanisms of their action will 
potentially provide pharmacological targets for the treatment of metabolic and 
cardiovascular disorders. 
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